HFA Premium Access

Prognostic value of serial measurements of gdf-15 in acute heart failure

Congress Presentation

About the speaker

Mr Muhammed Taha Gurgoze

Erasmus University Medical Centre, Rotterdam (Netherlands (The))
0 follower

8 more presentations in this session

Empagliflozin use versus dipeptidyl peptidase 4 inhibitors reduces risk of cardiovascular and renal disease among type 2 diabetes patients in routine care in europe and israel: EMPRISE study results

Speaker: Doctor L. Niskanen (Helsinki, FI)

Thumbnail

Testing for iron deficiency and use of ferric carboxymaltose in patients with heart failure: need for implementation? data from the swedish heart failure registry

Speaker: Doctor P. Becher (Hamburg, DE)

Thumbnail

Disparities in follow-up rates after heart failure hospitalisation decreased during the COVID-19 pandemic

Speaker: Doctor Z. Hughes (Chicago, US)

Thumbnail

Different renal function patterns in patients with acute heart failure: relationship with outcome and congestion

Speaker: Associate Professor A. Palazzuoli (Siena, IT)

Thumbnail

Readmissions in heart failure patients: a portuguese administrative database study from 2008 to 2017

Speaker: Mrs M. Pardal (Lisboa, PT)

Thumbnail

Access the full session

Acute Heart Failure - Epidemiology, Prognosis, Outcome

Speakers: Mr M. Gurgoze, Doctor L. Niskanen, Doctor P. Becher, Doctor Z. Hughes, Associate Professor A. Palazzuoli...
Thumbnail

About the event

Image

Heart Failure 2021

29 June - 1 July 2021

Sessions Presentations